PRECIOUS NEWS | ISSUE 8 | 04/2018
 
 
Link to website
 
 
PRECIOUS NEWS | ISSUE 8 | 04/2018
 
 

Content

Trial progress

Arrowe Park Hospital (UK), Aberdeen Royal Infirmary (UK) and Universitätsklinikum Heidelberg (DE) have officially been opened as participating centers! Heidelberg already included their first patient. Alesund Hospital (NO) has had the SIV, and will be open for recruitment soon! 

Top 5 recruiting centers overall*

1. Haaglanden Medisch Centrum, NL (15 patients). PI: Korné Jellema.

 

2. Nottingham University Hospital Trust, UK (11 patients). PI: Kailash Krishnan.

 

3. University Medical Center Hamburg Eppendorf, DE (10 patients). PI: Götz Thomalla.

3. Kings College Hospital, UK (10 patients). PI: Rohan Pathansali.

 

4. Calderdale Royal Hospital, UK (7 patients). PI: Anand Nair.

4. Azienda Socio Sanitaria Territoriale (ASST) di Mantova, IT (7 patients). PI: Alfonso Ciccone.

 

5. Academic Medical Center Amsterdam, NL (6 patients). PI: Diederik van de Beek

 

* With the exception of UMC Utrecht, NL (50 patients)

 

Top 3 recruiting centers last month

1.    Humanitas Research Hospital in Rozzano (IT): 5 patients. PI: Simona Marcheselli

2.    Nottingham University Hospital Trust (UK) and University Medical Center Hamburg (DE): 4 patients.

3.    Calderdale Royal Hospital (UK) and Ioannina University hospital (GR): 3 patients.

New prediction model of post-stroke pneumonia

In a recently accepted paper in the European Stroke Journal (ESJ), Willeke Westendorp and colleagues described a prediction model based on the data of the PASS trial. In this model,  post-stroke pneumonia was predicted by higher age, male sex, pre-stroke disability, medical history of chronic obstructive pulmonary disease, more severe stroke, dysphagia and intracerebral haemorrhage (rather than ischaemic stroke). Based on the prediction rule, risks for pneumonia ranged from 0.4% to 56.2%!

Higher age and more severe stroke were the most important predictors for post-stroke pneumonia. Therefore, this study provides additional evidence that preventive treatment strategies can best be tested in populations like that of PRECIOUS!

Total number of patients included: 177

 

 

 

Contact

Coordinator

University Medical Center Utrecht, The Netherlands
Dr. Bart van der Worp

Project Management

ARTTIC, Germany
Sophie Rau

 

Follow us on Twitter!

 
 
PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.
The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.
Copyright | Imprint PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.<br>The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.
 

If you no longer wish to receive our newsletter please click here to unsubscribe.

Having trouble viewing this email? Click here to view it in your browser.